199 results on '"Ganesan, Saravanan"'
Search Results
2. Genetic Modification in Vitamin-Rich Crop Biofortification
3. Single-cell multi-ome and immune profiles of the Inspiration4 crew reveal conserved, cell-type, and sex-specific responses to spaceflight
4. Ablation of Wnt signaling in bone marrow stromal cells overcomes microenvironment-mediated drug resistance in acute myeloid leukemia
5. Genomic and functional impact of Trp53 inactivation in JAK2V617F myeloproliferative neoplasms
6. Mapping genotypes to chromatin accessibility profiles in single cells
7. Cystatin F a potential diagnostic biomarker in acute promyelocytic leukemia
8. Single-cell multi-omics defines the cell-type-specific impact of splicing aberrations in human hematopoietic clonal outgrowths
9. Optimization and effect of dielectric fluid with Zr and Ni on electrical discharge machining of die steel material
10. Experimental Investigation on SS202 using Tubular and Double D Tubular Electrode Tool in Electrical Discharge Drilling Machining.
11. Metabolic adaptation drives arsenic trioxide resistance in acute promyelocytic leukemia
12. Correction: Activation of RAS/MAPK pathway confers MCL-1 mediated acquired resistance to BCL-2 inhibitor venetoclax in acute myeloid leukemia
13. Activation of RAS/MAPK pathway confers MCL-1 mediated acquired resistance to BCL-2 inhibitor venetoclax in acute myeloid leukemia
14. GoT-Splice protocol for multi-omics profiling of gene expression, cell-surface proteins, mutational status, and RNA splicing in human cells
15. Single-cell genotype-phenotype mapping identifies therapeutic vulnerabilities in VEXAS syndrome
16. JAK2V617F‐dependent down regulation of SHP‐1 expression participates in the selection of myeloproliferative neoplasm cells in the presence of TGF‐β.
17. Chapter Three - DOGMA-seq and multimodal, single-cell analysis in acute myeloid leukemia
18. Breast Cancer Macrophage Heterogeneity and Self-renewal are Determined by Spatial Localization
19. Stromal cells downregulate miR-23a-5p to activate protective autophagy in acute myeloid leukemia
20. Data from Combination Lenalidomide/Bortezomib Treatment Synergistically Induces Calpain-Dependent Ikaros Cleavage and Apoptosis in Myeloma Cells
21. Supplementary Figures 1-10 from Combination Lenalidomide/Bortezomib Treatment Synergistically Induces Calpain-Dependent Ikaros Cleavage and Apoptosis in Myeloma Cells
22. Analysis of fin characteristics for overall heat transfer in boiler economizer
23. DEVELOPMENT AND PERFORMANCE OPTIMIZATION OF ECM PARAMETERS ON SCRAPPED ALLOY WHEEL METAL MATRIX COMPOSITES
24. JAK Inhibition Mediates Clonal Selection of RAS Pathway Mutations in Myeloproliferative Neoplasms
25. Comprehensive Analysis of Mesenchymal Cells from Myeloproliferative Neoplasm (MPN) Patients Reveals the Role of HOXB7 in Myelofibrosis Induction
26. Role of minimal residual disease monitoring in acute promyelocytic leukemia treated with arsenic trioxide in frontline therapy
27. Single-cell multi-omics defines the cell-type specific impact of splicing aberrations in human hematopoietic clonal outgrowths
28. Integrated Single-Cell Genotyping and Chromatin Accessibility Charts JAK2V617F Human Hematopoietic Differentiation
29. Microenvironment and drug resistance in acute myeloid leukemia: Do we know enough?
30. BCL-2 Inhibitor ABT-737 Effectively Targets Leukemia-Initiating Cells with Differential Regulation of Relevant Genes Leading to Extended Survival in a NRAS/BCL-2 Mouse Model of High Risk-Myelodysplastic Syndrome
31. Genotype-Phenotype Mapping Via Single-Cell Multi-Omics Identifies Therapeutic Vulnerabilities in Vexas Syndrome
32. Wind turbine condition monitoring & classifying system using virtual SCADA and IOT: A machine learning approach.
33. Microenvironment and drug resistance in acute myeloid leukemia: Do we know enough?
34. Management of relapse in acute promyelocytic leukaemia treated with up‐front arsenic trioxide‐based regimens
35. Arsenic trioxide resistance in acute promyelocytic leukemia: More to it than PML mutations
36. Combination Lenalidomide/Bortezomib Treatment Synergistically Induces Calpain-Dependent Ikaros Cleavage and Apoptosis in Myeloma Cells
37. A phase II study evaluating the role of bortezomib in the management of relapsed acute promyelocytic leukemia treated upfront with arsenic trioxide
38. ANALYSIS OF FIN CHARACTERISTICS FOR OVERALL HEAT TRANSFER IN BOILER ECONOMIZER.
39. Optimization of Laser Parameters and Dimple Geometry Using PCA-Coupled GRG.
40. Targeting Extracellular Vesicle Secretion As a Strategy to Overcome Microenvironment Mediated Drug Resistance in Acute Myeloid Leukemia
41. T-Cell Protein Tyrosine Phosphatase Is Irreversibly Inhibited by Etoposide-Quinone, a Reactive Metabolite of the Chemotherapy Drug Etoposide
42. Comprehensive Analysis of Mesenchymal Cells from Myeloproliferative Neoplasm (MPN) Patients Reveals the Role of HOXB7in Myelofibrosis Induction
43. Management of relapse in acute promyelocytic leukaemia treated with up‐front arsenic trioxide‐based regimens.
44. Prevalence of FVIII inhibitors in severe haemophilia A patients: Effect of treatment and genetic factors in an Indian population
45. Arsenic Trioxide Enhances the NK Cell Cytotoxicity Against Acute Promyelocytic Leukemia While Simultaneously Inhibiting Its Bio-Genesis
46. Glutathione, glutathione-dependent enzymes and antioxidant status in gastric carcinoma patients
47. Changes in CD4+ cell count, lipid profile and liver enzymes in HIV infection and AIDS patients
48. Fate of Ikaros in Multiple Myeloma Cells Upon Treatment With Lenalidomide and Proteasome Inhibitor
49. Effect of chronic smoking on lipid peroxidation and antioxidant status in gastric carcinoma patients
50. Metabolic Rewiring Drives Resistance to Arsenic Trioxide in Acute Promyelocytic Leukemia
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.